Supplementary Material for: Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy

H., Imai ; T., Kishikawa ; H., Minemura ; Y., Yamada ; T., Ibe ; K., Mori ; O., Yamaguchi ; A., Mouri ; Y., Hamamoto ; K., Kanazawa ; T., Kasai ; K., Kaira ; T., Kaburagi ; K., Minato ; K., Kobayashi ; H., Kagamu

Karger Publishers 2021

Texto completo disponível